Aimmune Therapeutics, Inc.
12 clinical trials · Sponsor
◉ Watch Aimmune Therapeutics, Inc.
| Record | Firm | Date |
|---|---|---|
| Aimmune Longitudinal Collaboration Study (NCT07218640) | Aimmune Therapeutics, Inc. | 2025-10-01 |
| Oral Immunotherapy for Desensitization in Children, Adolescents, and Young Adults With Hen Egg Allergy (NCT04056299) | Aimmune Therapeutics, Inc. | 2019-08-20 |
| Peanut Oral Immunotherapy Study of Early Intervention for Desensitization (NCT03736447) | Aimmune Therapeutics, Inc. | 2018-12-27 |
| Real World, Open Label, QOL Assessment of Peanut Immunotherapy AR101 in Children and Adolescents (NCT03703791) | Aimmune Therapeutics, Inc. | 2018-10-24 |
| Longer-term Study of AR101 in Subjects Who Participated in a Prior AR101 Study (ARC008) (NCT03292484) | Aimmune Therapeutics, Inc. | 2017-11-02 |
| AR101 Real-World Open-Label Extension Study (NCT03337542) | Aimmune Therapeutics, Inc. | 2017-10-18 |
Track Aimmune Therapeutics, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.